OBJECTIVES: To explore the relationship between severity of pelvic organ prolapse (POP), symptoms of pelvic dysfunction and quality of life using validated measures. METHOD: Baseline data from 314 participants in the Colpopexy And Urinary Reduction Efforts (CARE) trial were analyzed. Pelvic symptoms and impact were assessed using the Pelvic Floor Distress Inventory (PFDI) and the Pelvic Floor Impact Questionnaire (PFIQ). PFDI and PFIQ scores were compared by prolapse stage and history of incontinence or POP surgery. Regression analyses were performed to identify other predictors of symptoms and impact. RESULTS: Women were predominantly (90%) Caucasian and had mean age of 61 years. Women with stage II POP, especially those with prior surgery, reported more symptoms and impact than women with more advanced POP. There were no other significant predictors of symptoms or life impact. CONCLUSIONS:Women planning sacrocolpopexy with stage II prolapse and prior pelvic surgery reported more symptoms and quality of life impact than those with more advanced prolapse.
RCT Entities:
OBJECTIVES: To explore the relationship between severity of pelvic organ prolapse (POP), symptoms of pelvic dysfunction and quality of life using validated measures. METHOD: Baseline data from 314 participants in the Colpopexy And Urinary Reduction Efforts (CARE) trial were analyzed. Pelvic symptoms and impact were assessed using the Pelvic Floor Distress Inventory (PFDI) and the Pelvic Floor Impact Questionnaire (PFIQ). PFDI and PFIQ scores were compared by prolapse stage and history of incontinence or POP surgery. Regression analyses were performed to identify other predictors of symptoms and impact. RESULTS:Women were predominantly (90%) Caucasian and had mean age of 61 years. Women with stage II POP, especially those with prior surgery, reported more symptoms and impact than women with more advanced POP. There were no other significant predictors of symptoms or life impact. CONCLUSIONS:Women planning sacrocolpopexy with stage II prolapse and prior pelvic surgery reported more symptoms and quality of life impact than those with more advanced prolapse.
Authors: Sarah A Collins; Michele O'Shea; Nicola Dykes; Olga Ramm; Autumn Edenfield; Ka Lai Shek; Kim van Delft; Molly Beestrum; Kimberly Kenton Journal: Int Urogynecol J Date: 2021-06-30 Impact factor: 2.894
Authors: Deborah L Myers; Vivian W Sung; Holly E Richter; Jennifer Creasman; Leslee L Subak Journal: Female Pelvic Med Reconstr Surg Date: 2012 Jan-Feb Impact factor: 2.091
Authors: John T Wei; Rodney Dunn; Ingrid Nygaard; Kathryn Burgio; Emily S Lukacz; Alayne Markland; Patricia A Wren; Linda Brubaker; Matthew D Barber; J Eric Jelovsek; Cathie Spino; Susie Meikle; Nancy Janz Journal: Female Pelvic Med Reconstr Surg Date: 2017 Jul/Aug Impact factor: 2.091
Authors: Filip Claerhout; Philip Moons; Sophie Ghesquiere; Jasper Verguts; Dirk De Ridder; Jan Deprest Journal: Int Urogynecol J Date: 2010-01-16 Impact factor: 2.894
Authors: Victoria L Handa; Matthew D Barber; Stephen B Young; Michael P Aronson; Abraham Morse; Geoffrey W Cundiff Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2008-05-17